Reanalysis of the Multi‐Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic‐Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et al

Detalles Bibliográficos
Autores principales: Curtis, Jeffrey R., Wright, Grace C., Strand, Vibeke, Davis, Charles S., Hitraya, Elena, Sasso, Eric H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749941/
https://www.ncbi.nlm.nih.gov/pubmed/27813312
http://dx.doi.org/10.1002/art.39981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749941/
https://www.ncbi.nlm.nih.gov/pubmed/27813312
http://dx.doi.org/10.1002/art.39981

Ejemplares similares